Hull is facing a surge in respiratory infections in children, a doctor said. Dr Kavitha Tharian, a consultant in paediatrics ...

The coverage rate of maternal vaccination against respiratory syncytial virus stood at 11.6 percent in Japan due to the high ...

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and ...

As the winter season continues, there's an increased chance of infections from COVID-19, influenza and respiratory syncytial virus. But, the U.S. Centers for Disease Control and Prevention predicted ...

Respiratory illness activity – a measure of how often conditions like the common cold, flu, COVID-19, and respiratory syncytial virus are diagnosed – is currently "high" in the United States, ...

Giving the long-acting monoclonal antibody nirsevimab to most infants sharply reduced hospitalizations and clinic visits ...

Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED) visits ...

Children with chronic medical conditions (CMCs) had higher rates of respiratory syncytial virus (RSV)-related hospitalization than healthy children during their first two RSV seasons, with a sustained ...

Respiratory syncytial virus (RSV) is a common virus that affects the throat, nose, and lungs. Symptoms include a runny nose, congestion, sneezing, wheezing, cough, and fever, and these are often mild ...

Shingrix is approved to prevent shingles (herpes zoster) in adults aged 50 and older. Arexvy is approved for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial ...

With levels of respiratory viruses like the flu, COVID-19, and respiratory syncytial virus (RSV) very high in Rhode Island ...